Active Ingredient(s):Eravacycline Dihydrochloride FDA Approved: * August 27, 2018 Pharm Company: *TETRAPHASE PHARMS Category:Antibiotics
Eravacycline (TP-434, Xerava) is a synthetic halogenated tetracycline class antibiotic in development by Tetraphase Pharmaceuticals. It is closely related to tigecycline. It has a broad spectrum of activity including many multi-drug resistant strains of bacteria. Phase III studies in complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI) were recently completed with mixed results. Eravacycline has been granted fast t...
* May have multiple approval dates, manufacturers, or labelers.
Xerava 50 mg Intravenous Injection, Powder, Lyophilized, for Solution